Wolverine Asset Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-309,224
Closed -$2.8M 1711
2020
Q1
$2.8M Sell
309,224
-281,849
-48% -$2.67M 0.04% 298
2019
Q4
$6.07M Sell
591,073
-60,149
-9% -$682K 0.07% 217
2019
Q3
$9.43M Sell
651,222
-23,844
-4% -$369K 0.12% 146
2019
Q2
$10.9M Sell
675,066
-11,963
-2% -$162K 0.14% 132
2019
Q1
$8.74M Sell
687,029
-11,953
-2% -$155K 0.12% 159
2018
Q4
$7.67M Buy
698,982
+51,840
+8% +$767K 0.09% 207
2018
Q3
$11.6M Sell
647,142
-97,606
-13% -$1.23M 0.14% 157
2018
Q2
$7.75M Buy
+744,748
New +$7.65M 0.1% 201

Other funds holding OPRX

Wolverine Asset Management's OPRX Position: Q2 2020 in Review

Wolverine Asset Management sold out of OptimizeRx (OPRX) in Q2 2020, closing a stake of 309,224 shares — an estimated $2.8M sold.

Wolverine Asset Management first reported a position in OPRX in Q2 2018 and held it in 8 quarters. The position peaked at $11.6M in Q3 2018. 53 funds tracked by Wall St. Rank hold OPRX as of Q2 2020.

  • Wolverine Asset Management reported no remaining OptimizeRx position as of Q2 2020 after selling out during the quarter.
  • Wolverine Asset Management sold 309,224 OptimizeRx shares in Q2 2020, an estimated $2.8M.
  • Wolverine Asset Management first reported a position in OptimizeRx in Q2 2018 and held it in 8 quarters.
  • Wolverine Asset Management's OptimizeRx position peaked at $11.6M in Q3 2018.
  • 53 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2020.

Based on Wolverine Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.